Explore the vital role of academic reform in strengthening paramedics and allied health professionals for a resilient ...
CKD patients face higher CVD risk, with dyslipidemia differing from the general population, necessitating tailored lipid ...
Dysparathyroidism, encompassing both hyperparathyroidism and hypoparathyroidism, significantly affects calcium and phosphate ...
Familial Hypobetalipoproteinemia (FHBL), caused by variants in the apolipoprotein B (APOB) gene, is a rare autosomal ...
Bone and tissue infection, or osteomyelitis, is a major hurdle in orthopedic medicine, often manifesting as chronic pain, disrupted nerve signaling, ...
| DelveInsight The gastroesophageal reflux disease market continues to be constrained by a limited number of approved treatment options and persistent unmet needs, particularly among patients who do ...
Welcome, everyone, to the JPMorgan Healthcare Conference. We are pleased to have with us the Almirall management team here with us today, Carlos Gallardo, Chairman and CEO; Karl Ziegelbauer, CFO; Jon ...
Objectives The TREAT EARLIER trial showed in clinically suspect arthralgia (CSA) that methotrexate induced reductions in ...
A new scientific review published in the journal Pathophysiology examines how cannabinoids—both those produced naturally in ...
The cystinosis therapeutic landscape remains dominated by established cysteamine-based treatments, with limited availability of next-generation, curative, or truly disease-modifying options. However, ...
A look at Amyotrophic Lateral Sclerosis (ALS), focusing on motor neuron degeneration, sporadic versus familial ...